Medicamento | Forma farmacêutica | Composição | Observações |
---|---|---|---|
albendazole | tablet | 200mg | |
chloroquine | tablet | 150mg (phosphate) | |
hydroxychloroquine | tablet | 400mg (sulfate) or 310mg (pure) | |
ivermectin | tablet | 6 mg | |
meglumine antimoniate | Injection | 300mg/ml | |
metronidazole | tablet | 500 mg | |
metronidazole | oral liquid | 125 mg (benzoate)/5 mL | |
pirimetamine | tablet | 25 mg | |
primaquine | tablet | 15 mg (as diphosphate) | |
primaquine | tablet | 5 mg (phosphate) |
Medicamento | Forma farmacêutica | Composição | Observações |
---|---|---|---|
amikacin | Injection | 100 mg (sulfate)/2 mL | |
amikacin | Injection | 500 mg (sulfate)/2 mL | |
amoxicillin | powder for oral liquid | 250 mg (as trihydrate)/5 mL | |
amoxicillin | tablet | 500 mg | |
ampicillin | Powder for injection | 500 mg (as sodium salt) in vial | |
benzathine benzylpenicillin | Injection | 1 200 000 IU | |
benzylpenicillin | Powder for injection | 600 mg (= 1 million IU) (sodium or potassium salt) in vial | |
benzylpenicillin | Powder for injection | 3 g (= 5 million IU) (sodium or potassium salt) in vial | |
cefalexin | solid oral dosage form | 250 mg (as monohydrate) | |
cefalexin | capsule | 500 mg | |
cefalotine | Powder for injection | 1g | |
cefotaxime | Powder for injection | 1 g (as sodium salt) | |
ceftazidime | Powder for injection | 1 g (as pentahydrate) in vial | |
ceftriaxone | Powder for injection | 250 mg (as sodium salt) in vial | |
ciprofloxacin | tablet | 500mg (hydrochloride) | |
clarithromycin | Suspension | 250 mg/5 ml | |
clarithromycin | tablet | 500 mg | |
clindamycin | Injection | 600 mg | |
clofazimine | capsule | 50 mg | |
dapsone | tablet | 100 mg | |
doxycycline | capsule | 100 mg (as hydrochloride or hyclate) | |
ertapenem | Powder for injection | 1g | |
gentamicin | Injection | 40 mg (sulfate)/ml in 2-mL vial | |
levofloxacin | Injection | 500 mg/100 mL vial | |
meropenem | Powder for injection | 500mg | |
metronidazole | Injection | 500 mg in 100-mL vial | |
neomycin | tablet | 250 mg a 350 mg | |
oxacillin | Powder for injection | 1 g | |
piperacillin + beta-lactamase inhibitor | Injection | 4.5 g | |
spiramycin | tablet | 500 mg | |
sulfamethoxazole + trimethoprim | tablet | 800 mg + 160 mg | |
sulfamethoxazole + trimethoprim | oral liquid | 200 mg + 40 mg/5 mL | |
sulfasalazine | tablet | 500 mg | |
vancomycin | Injection | 500 mg (chlorohydrate) |
Medicamento | Forma farmacêutica | Composição | Observações |
---|---|---|---|
cycloserine | solid oral dosage form | 250 mg | |
ethambutol | tablet | 400mg (chlorohydrate) | |
ethambutol + isoniazid + pyrazinamide + rifampicin | tablet | 275 mg + 75 mg + 400 mg + 150 mg | |
ethionamide | tablet | 250 mg | |
isoniazid | tablet | 100mg | |
isoniazid | tablet | 300mg | |
isoniazid | oral liquid | 50 mg/5 ml | |
isoniazid + pyrazinamide + rifampicin | tablet (dispersible) | 50 mg + 150 mg + 75mg | |
isoniazid + rifampicin | tablet | 75 mg + 150 mg | |
isoniazid + rifampicin | tablet (dispersible) | 50 mg + 75 mg. | |
pyrazinamide | tablet | 500 mg | |
rifampicin | Suspension | 100mg/5ml | |
rifampicin | capsule | 300 mg |
Medicamento | Forma farmacêutica | Composição | Observações |
---|---|---|---|
abacavir (ABC) | tablet | 300 mg (as sulfate) | |
abacavir + lamivudine | tablet | 600 mg (como sulfato) + 300 mg | |
aciclovir | oral liquid | 200 mg/5 mL | |
aciclovir | tablet | 400 mg | |
aciclovir | Powder for injection | 250 mg (as sodium salt) in vial | |
amphotericin B | Powder for injection | 50 mg in vial | |
anidulafungina | Powder for injection | 100mg. | |
caspofungina | N/A | 70 mg | |
darunavir | tablet | 600 mg | |
dolutegravir | tablet | 50 mg | |
dolutegravir | tablet | 50 mg | |
dolutegravir + lamivudina + tenofovir disoproxil | tablet (enteric-coated) | 50 mg + 300 mg + 245 mg | |
efavirenz (EFV or EFZ) | tablet | 600 mg | |
efavirenz + emtricitabine + tenofovir | tablet | 600 mg + 200 mg + 300 mg | |
elvitegravir + cobicistat + emtricitabina + tenofovir alafenamida | tablet (enteric-coated) | 150 mg + 150 mg + 200 mg + 10 mg. | |
fluconazole | Injection | 2 mg/mL in vial | |
fluconazole | capsule | 200 mg | |
griseofulvin | oral liquid | 125 mg/5 ml | |
itraconazole | capsule | 100 mg | |
ketoconazole | tablet | 200 mg | |
lamivudine (3TC) | oral liquid | 10mg/ml | |
lamivudine (3TC) | tablet | 150 mg | |
lopinavir + ritonavir (LPV/r) | tablet (heat stable) | 200 mg + 50 mg | |
lopinavir + ritonavir (LPV/r) | oral liquid | 80 + 20 mg/ml | |
nystatin | oral liquid | 100 000 IU/ml | |
raltegavir | tablet | 400 mg | |
ritonavir | tablet (heat stable) | 100 mg | |
sofosbuvir + velpatasvir | tablet (enteric-coated) | 400 mg + 100 mg. | |
tenofovir disoproxil fumarate | tablet | 300 mg | |
zidovudine (ZDV or AZT) | Injection | 10 mg/mL | |
zidovudine (ZDV or AZT) | tablet | 300 mg | |
zidovudine (ZDV or AZT) | oral liquid | 50 mg/5 mL |
Medicamento | Forma farmacêutica | Composição | Observações |
---|---|---|---|
nitrofurantoin | oral liquid | 25 mg/5 ml | |
nitrofurantoin | capsule | 50mg o 100mg |
Medicamento | Forma farmacêutica | Composição | Observações |
---|---|---|---|
dobutamine | Injection | 12.5mg (hydrochloride)/mL in 20 ml vial | |
dopamine | Injection | 200 mg (hydrochloride) in 5-mL ampoule | |
epinephrine (adrenaline) | Injection | 1 mg (hydrochloride)/mL | |
norepinephrine | injectable solution | 4mg ampolla 4mL. | |
phenylephrine | Injection | 10 mg in 1-mL ampoule |
Medicamento | Forma farmacêutica | Composição | Observações |
---|---|---|---|
amiodarone | tablet (HCI) | 200 mg (hydrochloride) | |
amiodarone | Injection | 50 mg/mL in 3-mL ampoule (hydrochloride) | |
carvedilol | tablet | 12.5 mg | |
carvedilol | tablet | 6.25 mg | |
digoxin | eli | 0.05 mg/ml x 60 ml | |
digoxin | oral liquid | 0.75 mg/mL | |
digoxin | Injection | 250 micrograms/mL in 2-mL ampoule | |
digoxin | tablet | 250 mcg | |
enalapril | tablet | 5 mg (maleate) | |
indomethacin | Injection | 1 mg (sodium salt) | |
propranolol | Injection | 1mg (hydrochloride)/ml | |
propranolol | tablet | 10mg (hydrochloride) | |
verapamil | Injection | 5 mg (hydrochloride) in 2 ml ampoule | |
verapamil | tablet | 80 mg (hydrochloride) |
Medicamento | Forma farmacêutica | Composição | Observações |
---|---|---|---|
atenolol | tablet | 50 mg | |
enalapril | tablet | 20 mg (maleate) | |
hydralazine | tablet | 10mg (chlorohydrate) | |
hydralazine | Powder for injection | 20 mg (hydrochloride) in ampoule | |
hydralazine | tablet | 50 mg (hydrochloride) | |
hydrochlorothiazide | oral liquid | 50 mg/5 ml | |
hydrochlorothiazide | tablet (scored) | 25 mg | |
irbesartan | tablet | 150 mg | |
methyldopa | tablet | 250 mg | |
methyldopa | tablet | 500mg | |
propranolol | tablet | 40 mg (hydrochloride) | |
sodium nitroprusside | Powder for infusion | 50 mg in ampoule |
Medicamento | Forma farmacêutica | Composição | Observações |
---|---|---|---|
acetazolamide | tablet | 250 mg | |
furosemide | Injection | 20 mg/2 mL | |
furosemide | tablet | 40 mg | |
furosemide | tablet | 5 mg. | |
mannitol | injectable solution | 20% | |
spironolactone | tablet | 100mg |
Medicamento | Forma farmacêutica | Composição | Observações |
---|---|---|---|
amlodipine | tablet | 5 mg (besylate) | |
glyceryl trinitrate | tablet (sublingual) | 0.5 - 0.6 mg | |
glyceryl trinitrate | Solution for injection | 5 mg/ ml | |
isosorbide dinitrate | tablet | 20 mg. | |
nimodipine | tablet | 30 mg. |
Medicamento | Forma farmacêutica | Composição | Observações |
---|---|---|---|
acetylsalicylic acid | tablet | 100 mg | |
clopidogrel | tablet | 75 mg | |
enoxaparin | Injection | 40 mg/ 0.4 ml | |
enoxaparin | Injection | 80 mg. | |
heparin sodium | Injection | 1000 IU/mL in 1-mL ampoule | |
heparin sodium | Injection | 5000 IU/mL in 1-mL ampoule | |
streptokinase | Powder for injection | 1.5 million IU in vial | |
tirofiban | Injection | 0.25mg/ml | |
warfarin | tablet | 1 mg (sodium salt) | |
warfarin | tablet | 5 mg (sodium salt) |
Medicamento | Forma farmacêutica | Composição | Observações |
---|---|---|---|
aminocaproic acid | Injection | 250mg/ml | |
complex coagulant anti-inhibitor | Powder for injection | 500 U - 20 mL. | |
factor IX | Powder for injection | 500 IU | |
factor VIIa recombinante | Powder for injection | 2 mg | |
factor VIII concentrate | Powder for injection | 500 a 600 UI | |
factor VIII concentrate | Powder for injection | 250 a 300 UI | |
gelatine agents | N/A | N/A | |
phytomenadione | Injection | 1 mg/ 0.5 mL o 1mL - VIT K1 | |
phytomenadione | Injection | 10 mg/mL in 1-mL ampoule | |
protamine sulfate | Injection | 10 mg/mL | |
prothrombin complex concentrate | Injection | 500 a 600 UI |
Medicamento | Forma farmacêutica | Composição | Observações |
---|---|---|---|
cholestyramine | powder for oral administration | 4-g sachet | |
cyanocobalamin | Injection | 1 mg/ml | |
epoetin alpha | Injection | 2000 IU/ml in 1ml vial | |
epoetin beta | Injection | 4000 U/ 0.3 ml | |
ferrous fumarate | tablet (enteric-coated) | 200 mg (equivalent 66 mg iron) | |
folic acid | tablet | 1 mg | |
gemfibrozil | tablet | 600mg | |
iron | Injection | 50 mg (dextran complex)/mL | |
lovastatin | tablet | 20mg |
Medicamento | Forma farmacêutica | Composição | Observações |
---|---|---|---|
alendronic acid | tablet | 70mg (as alendronate sodium) | |
diclofenac | Injection | 75 mg/3 mL | |
ibuprofen | tablet | 400 mg | |
indomethacin | Suppository | 100 mg | |
indomethacin | solid oral dosage form | 25 mg | |
leflunomide | tablet | 20 mg | |
penicillamine | capsule | 125 mg. | |
penicillamine | solid oral dosage form | 250 mg | |
sulindraco | tablet | 200 mg. | |
tenoxicam | tablet (enteric-coated) | 20 mg. | |
zoledronic acid | Injection | 4 mg in vial |
Medicamento | Forma farmacêutica | Composição | Observações |
---|---|---|---|
allopurinol | tablet | 100 mg | |
allopurinol | tablet | 300 mg | |
colchicine | tablet | 0.5mg |
Medicamento | Forma farmacêutica | Composição | Observações |
---|---|---|---|
dipyrone (metamizole sodium) | Injection | 500 mg/ml | |
ibuprofen | Suspension | 100 mg/5 mL | |
paracetamol | Suppository | 300 mg | |
paracetamol | tablet | 500 mg | |
paracetamol | oral liquid | 100 mg/ml | |
paracetamol | oral liquid | 120 mg/5 mL | |
phenazopyridine hydrochloride | tablet (enteric-coated) | 100 mg. |
Medicamento | Forma farmacêutica | Composição | Observações |
---|---|---|---|
codeine phosphate + paracetamol | tablet | 30 mg + 500 mg. | |
fentanyl | Injection | 50 mcg (citrate)/mL | |
methadone | tablet | 5mg | |
methylphenidate | tablet | 10 mg (hydrochloride) | |
morphine | tablet (prolonged release) | 30 mg (morphine sulfate) | |
morphine | Injection | 10 mg (sulfate or hydrochloride) in 1-ml ampoule | |
morphine sulfate | tablet | 20 mg. | |
morphine sulfate | oral solution | 20 mg/mL. | |
tramadol | oral liquid | 100 mg (hydrochloride)/mL (as drops) | |
tramadol | Injection | 50 mg (hydrochloride)/mL |
Medicamento | Forma farmacêutica | Composição | Observações |
---|---|---|---|
droperidol | Injection | 2.5mg/ml | |
ketamine | Injection | 10 mg/ml x 20 mL | |
propofol | aqueous emulsion | 10 mg/mL | |
sevoflurane | nasal solution | 250ml | |
thiopental | Powder for injection | 0.5 g (as sodium) |
Medicamento | Forma farmacêutica | Composição | Observações |
---|---|---|---|
bupivacaine | Injection | 0.5% (hydrochloride) without preservant | |
levobupivacaine hidrocloride | Solution for injection | 0.5% - 10 mL. | |
lidocaine | Gel | 2% | |
lidocaine | Injection | 2% (hydrochloride) + epinephrine 1:200 000 in vial + preservant | |
lidocaine | Injection | 2% (hydrochloride) with preservant in 20 mL vial | |
lidocaine | Injection | 2% (without preservant) | |
lidocaine | solution topical | 10% (100mg/mL) | |
lidocaine hydrochloride + chlorhexidine dihydrochloride | Gel | 2% (20 mg/g) + 0.05% (0.5 mg/g) | |
lidocaine hydrochloride + epinefrina | Solution for injection | 2% (20 mg/mL) + 1:80.000 - 1.8 mL. | |
mepivacaine | dental cartridge | 3% |
Medicamento | Forma farmacêutica | Composição | Observações |
---|---|---|---|
atracurium | Injection | 10 mg/mL (besylate) | |
botulinum toxin A | Injection | 100 or 200 Units in single-use vial | |
pancuronium | Injection | 2 mg (bromuro)/mL | |
succinylcholine chloride | Injection | 50 mg/mL x 10 mL. |
Medicamento | Forma farmacêutica | Composição | Observações |
---|---|---|---|
atropine | Injection | 0.5 mg (sulphate) in 1-mL ampoule | |
hyoscine butylbromide | Injection | 20 mg in 1-mL ampoule | |
hyoscine butylbromide | tablet | 10mg | |
oxibutinine hidrochloride | tablet | 5mg. |
Medicamento | Forma farmacêutica | Composição | Observações |
---|---|---|---|
betanecol | tablet | 10 mg. | |
neostigmine | tablet | 15 mg (bromide) | |
neostigmine | Injection | 0,5 mg/ml |
Medicamento | Forma farmacêutica | Composição | Observações |
---|---|---|---|
aminophylline | Injection | 250 mg x 10 ml | |
beclometasone | inhalation (aerosol) | 100 micrograms (dipropionate) per dose (as CFC free forms) | |
fluticasone propionate | inhalation | 250 mcg | |
formoterol fumarate dihydrate | powder for inhalacion | 12 ug/dosis | |
ipratropium bromide | inhalation (aerosol) | 20 micrograms/metered dose | |
ipratropium bromide | Solution | 250 mcg/ ml | |
montelukast | tablet | 10 mg | |
montelukast | tablet (chewable) | 5 mg | |
salbutamol | respirator solution for use in nebulizers | 0.5% | |
salbutamol | metered dose inhaler (aerosol) | 0.1 mg/dose | |
salbutamol | oral liquid | 2 mg/5 mL | |
salbutamol | tablet | 4 mg | |
theophylline | tablet | 150 mg. | |
theophylline | eli | 50 mg/ 5 mL. | |
theophylline | tablet (prolonged release) | 250 mg | |
tiotropium bromide monohydrate | solution for inhalation | 2.5 mcg |
Medicamento | Forma farmacêutica | Composição | Observações |
---|---|---|---|
dextromethorphan | oral liquid | 15mg (hydrobromide)/5ml | |
dextromethorphan | tablet | 15 mg. |
Medicamento | Forma farmacêutica | Composição | Observações |
---|---|---|---|
aprepitant | capsule | 125 mg/2 x 80 mg | |
chlorphenamine | Injection | 10 mg (hydrogen maleate) in 1-ml ampoule | |
chlorphenamine | oral liquid | 2 mg/5 ml (hydrogen maleate) | |
chlorphenamine | tablet | 4 mg (hydrogen maleate) | |
dimenhydrinate | Suppository | 100 mg | |
dimenhydrinate | Injection | 50 mg/ ml x 5 ml | |
dimenhydrinate | tablet | 50 mg | |
dimenhydrinate | Suppository | 25 mg. / 1 gr. | |
diphenhydramine | capsule | 50 mg | |
diphenhydramine | Syu | 12.5 mg/ 5 ml | |
fexofenadine hydrochloride | tablet (enteric-coated) | 120 mg. | |
hydroxyzine | tablet | 25 mg | |
hydroxyzine | oral suspension | 10 mg/ 5 ml | |
loratadine | Syu | 5 mg/ 5 ml | |
tropisetron | Solution for injection | 5 mg |
Medicamento | Forma farmacêutica | Composição | Observações |
---|---|---|---|
biperiden | tablet | 2 mg (hydrochloride) | |
biperiden | Injection | 5 mg (lactate) in 1-ml ampoule | |
levodopa + benserazide | tablet | 200 mg + 50 mg | |
levodopa + carbidopa | tablet | 100 mg/ 25 mg |
Medicamento | Forma farmacêutica | Composição | Observações |
---|---|---|---|
ergotamine + caffeine | tablet | 1 mg (tartrate) + 100 mg |
Medicamento | Forma farmacêutica | Composição | Observações |
---|---|---|---|
carbamazepine | Suspension | 2% x 100 ml | |
carbamazepine | tablet | 200 mg | |
clonazepam | tablet | 2mg | |
clonazepam | oral liquid | 2.5 mg/ml | |
gabapentin | capsule | 300 mg. | |
lamotrigine | tablet | 100 mg | |
lamotrigine | tablet | 25 mg | |
phenobarbital | tablet | 100 mg | |
phenobarbital | tablet | 25 mg. | |
phenobarbital | Solution for injection | 50 mg/mL - ampoule 1mL | |
phenytoin | capsule | 100 mg | |
phenytoin | Injection | 50 mg/mL | |
phenytoin | Suspension | 2.5% (125 mg/mL) | |
primidone | tablet | 250 mg | |
primidone | Suspension | 250 mg/ 5mL | |
valproic acid (sodium valproate) | Solution | 200 mg/ml | |
valproic acid (sodium valproate) | tablet | 250 mg | |
vigabatrin | tablet | 500 mg |
Medicamento | Forma farmacêutica | Composição | Observações |
---|---|---|---|
amitriptyline | tablet | 10 mg | |
clomipramine | tablet | 75mg | |
clomipramine | tablet | 25 mg | |
fluoxetine | capsule | 20 mg | |
imipramine chlorohydrate | tablet | 25mg | |
imipramine chlorohydrate | solid oral dosage form | 10mg | |
venlafaxine | capsule | 75 mg |
Medicamento | Forma farmacêutica | Composição | Observações |
---|---|---|---|
chlorpromazine | Injection | 25 mg (hydrochloride)/mL in 2-mL ampoule | |
chlorpromazine | tablet (enteric-coated) | 100 mg (hydrochloride) | |
clozapine | tablet | 100mg | |
fluphenazine | Injection | 25 mg (decanoate)/mL | |
haloperidol | oral liquid | 0.2% | |
haloperidol | tablet | 5 mg | |
haloperidol | Injection | 5 mg/mL in 1-mL ampoule | |
levomepromazine | tablet | 25 mg (maleate) | |
lithium carbonate | tablet | 300 mg | |
olanzapine | Powder for injection | 10 mg. | |
perphenazine | tablet | 4 mg. | |
risperidone | tablet | 1mg | |
risperidone | Solution | 1 mg/ml | |
trifluoperazine | tablet | 5 mg (chlorohydrate) |
Medicamento | Forma farmacêutica | Composição | Observações |
---|---|---|---|
aluminum + magnesium hydroxide | Suspension | 4.7% a 6.1% p/p y 1.4% a 2.2% p/p, F.E.U. | |
aluminum + magnesium hydroxide | tablet (chewable) | 200 mg/ 200 mg | |
aluminum hydroxide | tablet (chewable) | 200 a 300 mg. | |
aluminum hydroxide | Suspension | 5.5 a 6.7% p/p | |
bismuth subsalicylate | oral suspension | 17.5% | |
cimetidine | Injection | 300 mg in 2-mL ampoule | |
cimetidine | Solution | 200 mg / 5mL | |
famotidine | tablet | 40mg | |
mesalazine | Suppository | 1 g | |
mesalazine | tablet (prolonged release) | 500 mg. | |
metoclopramide | tablet | 10 mg (hydrochloride) | |
metoclopramide | Injection | 10 mg (hydrochloride)/2 mL | |
octreotide | Solution for injection | 0.1 mg/mL - 1mL | |
octreotide | Powder for injection | 20 mg. | |
octreotide | Powder for injection | 30 mg. | |
omeprazole | capsule (delayed release) | 20 mg | |
omeprazole | capsule (delayed release) | 10 mg | |
omeprazole | Powder for injection | 40 mg | |
pancreatin | capsule | 16.000 unidades F.E.U. | |
pancreatin | capsule | 4000 unidades F.E.U. | |
trientine | capsule | 250 mg | |
ursodeoxycholic acid | capsule | 250 - 300 mg. | |
ursodeoxycholic acid | tablet | 150 mg |
Medicamento | Forma farmacêutica | Composição | Observações |
---|---|---|---|
bisacodyl | Suppository | 10 mg | |
glycerine | Suppository | 1gr. a 1.5 gr. | |
glycerine | Suppository | 2gr. a 2.6 gr. | |
hydrophilic psyllium muciloid + excipients | Powder | 49.70 g + 50.30 g - 200 gr. | |
lactulose | oral solution | 3.3 g/5 mL. | |
laxative | enema | 5 mL. | |
loperamide | capsule | 2 mg | |
magnesium hydroxido | oral suspension | F.E.U. 7.0% a 8.5% | |
mineral oil | oral oily solution | 110 - 120 ml | |
ricin oil | Oily solution | N/A | |
sodium biphosphate/ phos enema | oral solution | N/A |
Medicamento | Forma farmacêutica | Composição | Observações |
---|---|---|---|
dexamethasone | tablet | 0.5 mg | |
dexamethasone | Injection | 4 mg (phosphate)/mL | |
fludrocortisone | tablet | 100 mcg (acetate) | |
hydrocortisone | tablet | 20 mg | |
hydrocortisone | tablet | 5 mg | |
hydrocortisone | Injection | 100 mg (as sodium succinate) | |
methylprednisolone | Injection | 500 mg (sodium succinate) | |
prednisolone | tablet | 5 mg | |
prednisolone | tablet | 25 mg | |
prednisolone | tablet | 1 mg. | |
prednisolone | oral solution | 15 mg/ 5 mL. | |
triamcinolone | Injection | 10 mg/mL in 5-mL vial |
Medicamento | Forma farmacêutica | Composição | Observações |
---|---|---|---|
danazol | capsule | 200 mg | |
oximetolone | tablet | 50 mg. | |
testosterone | Injection | 250 mg (enanthate)/mL |
Medicamento | Forma farmacêutica | Composição | Observações |
---|---|---|---|
conjugated estrogens | tablet | 0.625 mg | |
estradiol | Oily injection | 10 mg/mL | |
estradiol | tablet | 2 mg | |
ethinylestradiol + levonorgestrel | tablet | 30 mcg + 150 mcg | |
etonogestrel | implant | 68 mg. | |
intrauterine contraceptive device | N/A | N/A | |
levonorgestrel | intrauterine | N/A | |
medroxyprogesterone acetate | Depot injection | 150 mg/mL in 1-mL vial | |
medroxyprogesterone acetate | tablet | 5 mg | |
norgestrel + ethinylestradiol | tablet | 0.5 mg + 0.05 mg | |
progesterone | capsule (softgel) | 200 mg | |
progesterone | Solution for injection | 100 mg - 1mL | |
progesterone | vaginal tablet | 8% |
Medicamento | Forma farmacêutica | Composição | Observações |
---|---|---|---|
dinoprostone | vaginal gel | 2 mg/ 2.5 mL | |
methylergometrine | Injection | 0.2 mg (maleate)/ml | |
oxytocin | Injection | 5 IU/mL | |
salbutamol | Injection | 1 mg/ mL - 5 mL |
Medicamento | Forma farmacêutica | Composição | Observações |
---|---|---|---|
bromocriptine mesylate | tablet | 2.5 mg | |
chorionic gonadotropin (human) | Injection | 250 mcg/0.5ml | |
chorionic gonadotropin (human) | Injection | 1000 IU/mL | |
clomifene | tablet | 50 mg (citrate) | |
desmopressin | nasal solution | 0.1 mg (acetate)/mL | |
goserelin | Injection | 3.6 mg | |
leuprorelin | Injection | 3.75 mg (acetate) | |
leuprorelin (leuprolide acetate) | Injection | 11.25 MG | |
menotropin | Injection | 75 IU | |
somatotropic hormone | Powder for injection | 5 mg in vial |
Medicamento | Forma farmacêutica | Composição | Observações |
---|---|---|---|
diazoxide | capsule | 50 mg. | |
glibenclamide | tablet | 5 mg | |
gliclazide | tablet | 80 mg | |
insulin injection (soluble) | Injection | 100 IU/ml in 10-ml vial | |
metformin | tablet | 500 mg (hydrochloride) |
Medicamento | Forma farmacêutica | Composição | Observações |
---|---|---|---|
levothyroxine | tablet | 25 mcg (sodium salt) | |
levothyroxine | tablet | 100 mcg (sodium salt) | |
liothyronine | tablet | 75 mg. | |
Lugol's solution | oral solution | 30 mL. | |
propylthiouracil | tablet | 50 mg |
Medicamento | Forma farmacêutica | Composição | Observações |
---|---|---|---|
anastrozole | tablet | 1mg | |
asparaginase | Powder for injection | 10 000 IU in vial | |
azathioprine | tablet | 50 mg | |
basiliximab | Powder for injection | 20 mg | |
bleomycin | Injection | 15 IU | |
capecitabine | tablet | 500 mg | |
carboplatin | Injection | 150 mg/15 mL | |
carboplatin | Injection | 450 mg/45 mL | |
chlorambucil | tablet | 2 mg | |
cisplatin | Powder for injection | 10 mg in vial | |
citarabine | Injection | 100 mg | |
citarabine | Injection | 500 mg | |
cyclophosphamide | Powder for injection | 500 mg in vial | |
cyclophosphamide | tablet | 50 mg | |
cyclosporine | oral liquid | 100 mg/ml | |
dacarbazine | Injection | 200 mg | |
dactinomycin | Powder for injection | 500 mcg in vial | |
docetaxel | Injection | 20 mg/ml | |
docetaxel | Solution for injection | 80 mg/ 4 ml | |
epirubicin | Injection | 50 mg/25 ml | |
erlotinib | tablet | 150 mg | |
etoposide | Injection | 20 mg/mL in 5-mL ampoule | |
exemestane | tablet | 25 mg | |
filgrastim | Injection | 30,000,000 IU | |
fluorouracil | Injection | 500mg/10ml | |
flutamide | tablet | 250 mg | |
gemcitabine | Injection | 1g (chlorohydrate) | |
gemcitabine | Injection | 200mg (chlorohydrate) | |
hydroxycarbamide | capsule | 500 mg | |
idarubicin | Powder for injection | 5 mg in 5 mL vial | |
ifosfamide | Powder for injection | 1 g in vial | |
imatinib | tablet | 400 mg (as mesylate) | |
interferon alpha 2B | Injection | 10 000 000 IU | |
interferon beta 1A | Solution for injection | 30 ug (6 millones U.I/ 0.5 mL) | |
interferon beta 1A | Solution for injection | 22 ug (6 millones U.I/ 0.5 mL) | |
interferon beta 1A | subcutaneous administration | 44UG/0,5ml | |
interferon beta 1B | Powder for injection | 0.25 mg. (8.0 mill. de U.I/ mL) | |
irinotecan | Solution for injection | 20 mg/ mL | |
melphalan | tablet | 2 mg | |
melphalan | Powder for injection | 50mg. | |
mercaptopurine | tablet | 50 mg | |
methotrexate | tablet | 2.5 mg (as sodium salt) | |
methotrexate | injection for intravenous administration | 50MG/2ML | |
methotrexate | Solution for injection | 1000 mg/ 10 ml | |
mitomycin | Injection | 5 mg | |
mycophenolate mofetil | capsule | 250 mg. | |
oxaliplatin | Injection | 50 mg | |
paclitaxel | Solution for injection | 6mg/mL | |
pazopanib | tablet | 200 MG | |
rituximab | Injection | 100 mg | |
rituximab | Injection | 500 MG/50 ML | |
Sunitinib (malate) | capsule | 50 mg. | |
tacrolimus | capsule | 0.5 mg | |
tacrolimus | capsule | 1 mg | |
tamoxifen | tablet | 20 mg (as citrate) | |
temozolomide | capsule | 100 MG | |
temozolomide | capsule | 20 mg | |
thalidomide | tablet | 100 mg | |
trastuzumab | Solution for injection | 600 mg/ 5 ml | |
tretinoin | capsule | 10 mg. | |
vinblastine | Powder for injection | 10 mg (sulfate) in vial | |
vincristine | Injection | 1 mg/mL |
Medicamento | Forma farmacêutica | Composição | Observações |
---|---|---|---|
ascorbic acid | oral liquid | 100 mg/mL | |
ascorbic acid | tablet | 500 mg | |
calcitriol | capsule | 0.25 mcg | |
calcitriol | capsule (softgel) | 1 mcg. | |
cholecalciferol | solution (eye drops) | 10000 UI/ 1 ml - 30 ml | |
isotretinoin | capsule | 10 mg. | |
multivitamins | Powder for injection | Pediatric | |
multivitamins | Powder for injection | N/A | |
pyridoxine | Injection | 50 mg in 1 ml ampoule (hydrochloride) | |
pyridoxine | tablet | 50mg (chlorohydrate) | |
retinol | capsule | 25 000 IU | |
thiamine | tablet | 100mg | |
thiamine | Injection | 100mg (chlorohydrate)/ml |
Medicamento | Forma farmacêutica | Composição | Observações |
---|---|---|---|
amino acids | Solution for injection | 10% | |
amino acids | Injection | 6% | |
balanced electrolyte solution | Solution for injection | with sodium gluconate - 1000 mL | |
balanced electrolyte solution | Solution for injection | 1000 mL | |
calcium carbonate | tablet | 750 mg | |
calcium gluconate | Injection | 100 mg/mL in 10-mL ampoule | |
dextran 40 | intravenous administration | 10% in 500-mL bottle | |
dextran 70 | injectable solution | 70 6% - 500 mL. | |
dextrose | injectable solution | 10% - 1000 mL. | |
dextrose | injectable solution | 10% - 250 mL. | |
dextrose | Solution for injection | 5% - 100mL | |
dextrose | Solution for injection | 5% - 1000 mL. | |
dextrose | Solution for injection | 5% - 50 mL | |
dextrose | Solution for injection | 5% - 500 mL. | |
dextrose | Solution for injection | 5% - 250 mL | |
dextrose | Solution for injection | 50% - 1000 mL. | |
dextrose | Solution for injection | 50% - 50 mL | |
dextrose + sodium chloride + potassium chloride | Solution for injection | 5% + 0.3% + 0.149% - 250 mL. | |
dextrose + sodium chloride + potassium chloride | Solution for injection | 5% + 0.3% + 0.149% - 500 mL. | |
Dextrose + sodium chloride + potassium chloride + sodium acetate | Solution for injection | 1% + 0.5% + 0.1% + 0.65% - 2000 mL | |
Dextrose + sodium chloride + potassium chloride + sodium acetate | Solution for injection | 2% + 0.35% + 0.15% + 0.4082 - 500 mL | |
hemodialysis solution | Solution | N/A | |
lipid emulsion | Injection | 20% | |
magnesium sulfate | Injection | 200 mg/mL in 10-mL ampoule | |
monobasic sodium phosphate + dibasic sodium phosphate | Injection | 224 mg + 236 mg / 15 mL. | |
oral rehydration salts | powder for oral administration | 6.7 gr | |
peritoneal dialysis solution | Solution | Dextrose 1.5% - 2000 mL. | |
peritoneal dialysis solution | Solution | Dextrose 4.25% - 2000 mL. | |
phosphates | sachet | 1 gr - 1.2 gr. | |
potassium chloride | Solution | 2 mEq/ml | |
potassium gluconate | oral liquid | 31.2% | |
sodium bicarbonate | Injection | 8.4% | |
sodium chloride | Solution | 0.9% 250 ml | |
sodium chloride | parenteral formulation | 0.9% (100 mL) | |
sodium chloride | Solution | 0.9% 500 ml | |
sodium chloride | Solution for injection | 9% / 50 ml | |
Sodium chloride + potassium chloride + magnesium chloride + calcium chloride | Solution for injection | 0.643% + 0.1193% + 0.3253% + 0.0176% - 1000 mL. | |
sodium chloride hypertonic | Injection | 4 molar | |
trace elements (oligoelementos) | Solution for injection | N/A | |
trace elements (oligoelementos) | Solution for injection | Pediatrics | |
water for injection | N/A | 10-ml ampoules |
Medicamento | Forma farmacêutica | Composição | Observações |
---|---|---|---|
albumin | Injection | 20%-25% | |
anti-D immunoglobulin (human) | Injection | 250-300 mcg/2 mL | |
anti-hepatitis B immunoglobulin | Injection | 200 UI/ ml | |
antitetanus immunoglobulin (human) | Injection | 250 UI | |
BCG vaccine | Powder for injection | multidose | |
diphtheria, tetanus toxoid | Solution for injection | 5 ml (multidose) | |
diphtheria, tetanus toxoid | Injection | 0.5 mL | |
diphtheria, tetanus toxoid + pertussis vaccine | Injection | N/A | |
haemophilus influenzae type b vaccine (Hib vaccine) | Injection | 1 dose | |
hepatitis B vaccine | Injection | pediatric | |
hepatitis B vaccine (recombinant) | Injection | 1 ml (1 dose) | |
HPV vaccine | Injection | 0.5 ml (1 dose) | |
Immunoglobulin IV | Solution for injection | 2.5 g (50 mg/mL) | |
Immunoglobulin Varicela Zoster | Solution for injection | 125 UI/mL. | |
influenza vaccine | Injection | 0.25 ml | |
influenza vaccine | Injection | 0.5 ml | |
MMR vaccine | Powder for injection | unit dose - multidose | |
MMR vaccine | Injection | 1 dose -preservative-free | |
MR vaccine | Injection | measles, rubella | |
ophidic antivenom | Solution for injection | anticoral - 10 mL. | |
ophidic antivenom | Solution for injection | N/A | |
pneumococcal vaccine -23 | Solution for injection | 0.5 mL - 1 dose | |
rabies vaccine | Injection | 1 dose | |
rotavirus vaccine | oral suspension | 1.5 mL - unica dosis. | |
vacuna sarampion y rubeola | Powder for injection | N/A | |
varicella vaccine | Powder for injection | N/A |
Medicamento | Forma farmacêutica | Composição | Observações |
---|---|---|---|
acetylcholine | solution (eye drops) | 20 mg/ 2 ml | |
aciclovir | Ointment | 3% W/W | |
atropine | solution (eye drops) | 1% (sulfate) | |
azul de tripano | Solution | 0.06% (0.6 mg/mL) - 0.5 mL | |
betamethasone sodium phosphate + neomycin sulphate | solution (eye drops) | 0.1% / 0.35% - 5mL | |
ciprofloxacin | topical | 0.3% drops (as hydrochloride) | |
cyclopentolate | solution (eye drops) | 1% (hydrochloride) | |
dorzolamide | solution (eye drops) | 2% (hydrochloride) | |
fluorometholone | solution (eye drops) | 0.1% | |
gentamicin | solution (eye drops) | 0.3% | |
hyaluronate sodium | Injection | 10 mg/ 1.0 ml | |
hyaluronidase | Injection | 150 IU | |
hypromellose | solution (eye drops) | 0.3% | |
hypromellose | solution (eye drops) | 0.3% | |
latanoprost | solution (eye drops) | 0.005% | |
normal saline | solution (eye drops) | 500 mL | |
olopatadine hcl | solution (eye drops) | 1% (1 mg/mL) - 5 mL | |
oxymethazoline | solution (eye drops) | 0.25 mg/ mL (hydrocloride) | |
phenylephrine | solution (eye drops) | 100 mg/ ml | |
phenylephrine+tropicamide | solution (eye drops) | 0.8% - 5 mL. | |
pilocarpine | solution (eye drops) | 2% (hydrochloride) | |
prednisolone | solution (eye drops) | 1% (acetate) | |
rivoflavin + dextran | Solution | > 0.1% p/v + 500 al 20% p/v. | |
Sodium hyaluronate + Sodium chondroitin sulfate | injectable solution | 30 mg/mL + 40 mg/mL | |
tetracaine | solution (eye drops) | 0.5% (hydrochloride) | |
tetracycline | Eye ointment | 10 mg (hydrochloride)/g | |
timolol | solution (eye drops) | 0.5% (maleate) |
Medicamento | Forma farmacêutica | Composição | Observações |
---|---|---|---|
acitretin | capsule | 25 mg. | |
aluminum acetate | Powder | N/A | |
antiseptic alcoholic solution | Solution | 350 mL / 500 mL. | |
benzoyl peroxide | Gel | 5% | |
betamethasone | cream | 0.1% (as valerate) | |
betamethasone | Ointment | 0.1% (as valerate) | |
bifonazol | cream | 1% | |
brea concentrated | shampoo | 150 mL / 180 mL. | |
calamine | Lotion | N/A | |
chlorhexidine | Solution | 4% (gluconate) | |
coal tar | Ointment | 28 gr - 45 gr. | |
crotamiton | Lotion | 10% | |
fluorouracil | cream | 5% | |
hydrocortisone | Lotion | 0.5% (acetate) | |
hydrocortisone | Ointment | 1% (acetate) | |
hydrocortisone | topical | 0.25% (acetate) | |
hydrogen peroxide | Solution | 3% | |
iodine-povidone | topical forms | 7-10% (foam and solution) | |
methoxsalen | tablet | 10 mg | |
mineral | oil | N/A | |
podophyllum resin | solution topical | 25% | |
potassium iodide | oral solution (drops) | 1g/mL - 30 mL | |
rose cream | cream | 40 g / 60 g. | |
salicylic acid | Ointment | 5% (50 mg/g) - 40-60 g | |
salicylic acid | solution topical | 15% - 17% | |
silver sulfadiazine | cream | 1% | |
silver sulfadiazine | cream | 1% (50g) | |
sodium fusidate | Ointment | 2% (20 mg/g) | |
sulisobenzone | Lotion | 10% | |
trioxisaleno | tablet | 5 mg. | |
zinc oxide | cream | 45/50/60 gr. |
Medicamento | Forma farmacêutica | Composição | Observações |
---|---|---|---|
conjugated estrogens | tablet | 0.625 mg | |
miconazole | Ovules | 200/400/1200 mg. (nitrate) | |
polycresulene | Gel | 18 mg/g. - 50g. | |
polycresulene | Ovules | 90 mg |
Medicamento | Forma farmacêutica | Composição | Observações |
---|---|---|---|
acetylcysteine | tablet (dispersible) | 600 mg. | |
deferasirox | tablet | 500 mg | |
flumazenil | Injection | 0.1 mg/ml | |
naloxone | Injection | 0.4 mg/mL | |
obidoxime | Injection | 250 mg (chloride)/mL |
Medicamento | Forma farmacêutica | Composição | Observações |
---|---|---|---|
antihemorrhoidal preparation (corticosteroid + local anesthetic) | Suppository | 1 gr/ 2gr | |
antihemorrhoidal preparation (corticosteroid + local anesthetic) | Ointment | 30 gr/ 60 gr. |
Medicamento | Forma farmacêutica | Composição | Observações |
---|---|---|---|
2% acetic acid in aluminum acetate solution | otic drops | 60 mL | |
acetic acid | topical | 2%, in alcohol | |
benzoin tincture 20% | Solution | 60 mL | |
oxymethazoline | solution (eye drops) | 0.25 mg/ mL (hydrocloride) | |
oxymethazoline | nasal spray | 0.5 mg/ml | |
Soften earwax (Potassium carbonate, glycerin or propylene glycol) | otic drops | 30 mL |
Medicamento | Forma farmacêutica | Composição | Observações |
---|---|---|---|
131 iodine (Na 131 I ) | capsule | 1 mCi - 200 mCi | |
131 iodine (Na 131 I ) | oral solution | 25 mCi - 200 mCi | |
99 mTc-Tropano | injectable solution | N/A | |
99mTc sodium pertechneciate | Injection | 74 GBq - 277.5 GBq | |
99mTc-colloidal sulfide | Powder for injection | N/A | |
99mTc-mebrophenin | Powder for injection | N/A | |
99mTc-oxidronato | Powder for injection | N/A | |
99mTc-pentetate | Powder for injection | N/A | |
99mTc-pyrophosphate | Powder for injection | N/A | |
barium sulfate | powder for oral suspension | 85% P/P | |
besilesomab marked with technetium (Tc-99m) | Powder for injection | N/A | |
colloidal rhenium sulfide (Nanocolloid) + 99 mTc | injectable solution | N/A | |
effervescent granules for oral use | oral solution | Ampoule 3 gr - 3,5 gr | |
gadoteric acid | Solution for injection | 0.5 mol/mL - 15mL | |
gallium Citrate (67 Ga) | aqueous solution | 1 mCi - 3 mCi / 5mL - 10 mL | |
gonadorelina | Powder for injection | 100 mcg | |
Indian marked Octreotid 111 | Powder for injection | 3 to 5 mCi | |
Iobenguano (131I) | injectable solution | 1.25 mCi to 1.5 mCi - 5 mL | |
iohexol | Injection | equiv 300mg iodo/ml in 50 or 100ml vial | |
iohexol | Injection | equiv 300mg iodo/ml in 50 or 100ml vial | |
meglumine and sodium ioxitalamate | Solution for injection | 55% (550 mg/mL) + iodine 25% - 20mL | |
meglumine diatrizoate | oral liquid | 66% + 10% sodium diatrizoate | |
norcolesterol iodado (131 I) | injectable solution | 1 mCi to 2 mCi - 2.5 mL to 10 mL | |
protirelin | injectable solution | 200 mcg. - 1 mL | |
rhenium (186 Re) colloidal sulfide | Injection | 220 MBq/mL to 335 MBq/mL | |
succimer | Powder for injection | for technetium 99mTc-succimer - ampoule | |
Technetium 99mTc-Albumin added | Powder for injection | N/A | |
Technetium 99mTc-bicisate | Powder for injection | N/A | |
Technetium 99mTc-Mertiatida | Powder for injection | N/A |
Medicamento | Forma farmacêutica | Composição | Observações |
---|---|---|---|
fluorescein | solution (eye drops) | 2% | |
fluorescein | Injection | 10% | |
gonadorelina | Powder for injection | 100 mcg | |
methylthioninium chloride (methylene blue) | Injection | 1% | |
protirelin | injectable solution | 200 mcg. - 1 mL | |
tuberculin, purified protein derivative (PPD) | Injection | N/A |
Medicamento | Forma farmacêutica | Composição | Observações |
---|---|---|---|
charcoal, activated | Powder | N/A | |
ethyl alcohol (ethanol) | Liq | FEU 95º | |
ethyl alcohol (ethanol) | Liq | FEU 95º | |
ethyl alcohol (ethanol) | Liq | FEU 95º | |
ethyl alcohol (ethanol) | Liq | FEU 95º |